Kovitz Investment Group Partners LLC Makes New Investment in Molina Healthcare, Inc. (NYSE:MOH)

Kovitz Investment Group Partners LLC acquired a new position in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 1,176 shares of the company's stock, valued at approximately $342,000.

Several other institutional investors have also modified their holdings of MOH. Wellington Management Group LLP increased its stake in Molina Healthcare by 7.4% in the 4th quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company's stock valued at $766,111,000 after buying an additional 181,073 shares during the last quarter. FMR LLC boosted its stake in Molina Healthcare by 31.1% in the 4th quarter. FMR LLC now owns 1,801,113 shares of the company's stock valued at $524,214,000 after purchasing an additional 427,276 shares during the period. Geode Capital Management LLC grew its stake in shares of Molina Healthcare by 2.5% in the fourth quarter. Geode Capital Management LLC now owns 1,436,909 shares of the company's stock valued at $417,144,000 after acquiring an additional 34,992 shares in the last quarter. Invesco Ltd. increased its holdings in shares of Molina Healthcare by 28.5% during the fourth quarter. Invesco Ltd. now owns 1,327,021 shares of the company's stock worth $386,229,000 after purchasing an additional 294,180 shares during the period. Finally, Dimensional Fund Advisors LP raised its holdings in Molina Healthcare by 15.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 688,245 shares of the company's stock valued at $200,307,000 after acquiring an additional 91,229 shares in the last quarter. Institutional investors own 98.50% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on MOH shares. Mizuho lifted their price target on Molina Healthcare from $376.00 to $400.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Baird R W lowered Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Barclays boosted their target price on shares of Molina Healthcare from $339.00 to $362.00 and gave the company an "equal weight" rating in a report on Friday, April 25th. Robert W. Baird reiterated a "neutral" rating and set a $375.00 target price (up previously from $331.00) on shares of Molina Healthcare in a research report on Tuesday, April 15th. Finally, Guggenheim assumed coverage on Molina Healthcare in a research report on Wednesday, April 9th. They set a "neutral" rating on the stock. Nine research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $365.38.

Insiders Place Their Bets

In other Molina Healthcare news, Director Richard M. Schapiro sold 669 shares of the business's stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total transaction of $214,414.50. Following the sale, the director now owns 11,244 shares of the company's stock, valued at approximately $3,603,702. The trade was a 5.62 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the business's stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total value of $28,005,250.00. Following the sale, the chief executive officer now owns 257,715 shares in the company, valued at approximately $82,484,262.90. The trade was a 25.35 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 89,169 shares of company stock worth $28,520,995 over the last quarter. Company insiders own 1.10% of the company's stock.

Molina Healthcare Price Performance

NYSE MOH traded down $3.01 during trading hours on Tuesday, reaching $316.62. The company's stock had a trading volume of 435,280 shares, compared to its average volume of 677,039. Molina Healthcare, Inc. has a 1 year low of $262.32 and a 1 year high of $365.23. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $17.16 billion, a price-to-earnings ratio of 15.50, a PEG ratio of 1.06 and a beta of 0.63. The firm's 50-day moving average price is $322.95 and its 200-day moving average price is $307.51.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.96 by $0.12. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. The business had revenue of $11.15 billion for the quarter, compared to analysts' expectations of $10.86 billion. During the same period in the prior year, the firm earned $5.73 EPS. The company's revenue for the quarter was up 12.2% on a year-over-year basis. On average, equities research analysts predict that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.